Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
JCO Global Oncology
|
January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis
Jing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.
Leukemia
|
August 3, 2021
Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Blood Advances
|
July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Shu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Ejhaem
|
February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database
Xuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Haematologica
|
March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
Xin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group Database
Ke Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Blood Advances
|
April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Fei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
JCO Global Oncology
|
January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis
Jing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.
Leukemia
|
August 3, 2021
Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Blood Advances
|
July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Shu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Ejhaem
|
February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database
Xuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Haematologica
|
March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
Xin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group Database
Ke Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Blood Advances
|
April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Fei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Page
of 6